Serial #98537469
LIVE

Serial Number

98537469

Owner

Ampersand Biomedicines, Inc.

Attorney

Christina Licursi

Filing Date

May 7, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98537469 Trademark

Serial Number: 98537469

Serial #98537469 is a trademark filed by Ampersand Biomedicines, Inc. on May 7, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Ampersand Biomedicines, Inc. (2 trademarks)

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

May 7, 2024

Registration Date

Not Registered

Published for Opposition

March 25, 2025

Goods & Services

Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services

Biological therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics, namely, therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; pharmaceutical preparations, namely, addressable and programmable protein-based therapeutics, for treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders

Biological and chemical agents for scientific use other than for medical use, namely, addressable and programmable protein-based therapeutics

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 16, 2026 EXRA
SOU EXTENSION 2 GRANTED
May 15, 2026 EX2G
SOU EXTENSION 2 FILED
May 15, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
May 15, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 20, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 19, 2025 EX1G
SOU EXTENSION 1 FILED
Nov 19, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 19, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 20, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 21, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 21, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 20, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 4, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2024 NWOS
NEW APPLICATION ENTERED
May 7, 2024 NWAP